羅普特(688619.SH):基於AI識別技術的智慧城市多元共建系統已完成研發
格隆匯3月10日丨羅普特(688619.SH)在互動平臺表示,基於AI識別技術的智慧城市多元共建系統已完成研發,該系統通過自然語言處理技術,可以自動解析和處理民衆的政務諮詢,提高政務服務的效率和質量。 公司牽頭負責的“存算一體化AI芯片研製”課題已驗收,相關技術可用於嵌入式設備和計算存儲設備的研發,相關的場景應用及產業化仍在積極探索中,公司將持續加強 AI 核心技術研發投入,增強科技創新能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.